Gautam Patel, Director at Amneal Pharmaceuticals, Inc. (AMRX), sold 8,668 shares at $8.00 ($69K) on 2025-05-02, disclosed to the SEC on 2025-05-06.
Scheduled sale ($69k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $8.00 | 3,768 | $30K | 43.5% |
| 2 | $8.00 | 4,900 | $39K | 56.5% |
| Total | $8.00 avg | 8,668 | $69K | 100% |
| Filing → |
| AMRX | SELL | 2025-04-02 | $664K | — | Filing → |
| AMRX | SELL | 2025-03-05 | $712K | — | Filing → |
| AMRX | SELL | 2025-02-05 | $651K | — | Filing → |